Flagship Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Flagship Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,000	Closed	–	–	401
2025 Q1	$0	Buy	1,000 +500	+100%	–	﹤0.01%	391
2024 Q4	$0	Buy	+500	New	–	﹤0.01%	373

Other funds holding SRNE

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Flagship Wealth Advisors's SRNE Position: Q2 2025 in Review

Flagship Wealth Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2025, closing a stake of 1,000 shares.

Flagship Wealth Advisors first reported a position in SRNE in Q4 2024 and held it in 2 quarters. The position peaked at $0 in Q1 2025. 2 funds tracked by Wall St. Rank hold SRNE as of Q2 2025.

Flagship Wealth Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2025 after selling out during the quarter.
Flagship Wealth Advisors sold 1,000 Sorrento Therapeutics, Inc. shares in Q2 2025.
Flagship Wealth Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2024 and held it in 2 quarters.
Flagship Wealth Advisors's Sorrento Therapeutics, Inc. position peaked at $0 in Q1 2025.
2 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2025.

Based on Flagship Wealth Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.